MTAP and cancer: In cancers, a complete loss of MTAP expression (MTAP deficiency) was seen in 33 (0.3 %) of informative samples, while the MTAP staining was considered 1+ in 14.8 %, 2+ in 42.2 %, and 3+ in 42.7 % of tumors.